טוען...
Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
BACKGROUND: Despite the progress made in the clinical management of metastatic melanoma, a patient’s response to treatment cannot be fully predicted, and intrinsic or acquired resistance that is developed in most melanoma patients warrants further research efforts. In addition to genetic factors, mi...
שמור ב:
| הוצא לאור ב: | Cancer Manag Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501594/ https://ncbi.nlm.nih.gov/pubmed/32982400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S263767 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|